Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure (AllodermRCT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Women's College Hospital
Vancouver General Hospital
Canadian Breast Cancer Foundation
Tom Baker Cancer Centre
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00956384
First received: August 7, 2009
Last updated: March 21, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):